| 摘要 |
<p>Disclosed are novel substituted 1-aralkyl-1,2-dihydropyrimidine-2-thiones of structure (I), processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them and a method of inhibiting dopamine-β-hydroxylase activity.</p> |
